Myocarditis and idiopathic dilated cardiomyopathy

Area of Science:

• Cardiology
• Pathology

Background:

• Idiopathic dilated cardiomyopathy (IDC) represents a significant portion of heart failure cases in the US.
• Understanding the triggers and progression of IDC remains a challenge, with current treatments being palliative.
• Active myocarditis, characterized by myocardial inflammation without ischemia, is a suspected precursor to IDC.

Purpose of the Study:

• To review the current understanding of myocarditis as a precursor to idiopathic dilated cardiomyopathy.
• To discuss the diagnostic advancements and therapeutic strategies for myocarditis and IDC.

Main Methods:

• Review of literature on myocarditis and idiopathic dilated cardiomyopathy.
• Discussion of diagnostic tools including endomyocardial biopsy and the Dallas criteria.
• Analysis of therapeutic approaches for heart failure and myocarditis.

Main Results:

• Myocarditis can range from mild to severe, potentially leading to arrhythmias, heart failure, or death.
• Clinical presentation of myocarditis depends on the interplay between the inciting agent and host response.
• Murine models and endomyocardial biopsy have improved the understanding of myocarditis and its outcomes.

Conclusions:

• Current therapy for IDC focuses on managing heart failure symptoms.
• Immunosuppressive therapy is indicated for biopsy-proven myocarditis refractory to conventional treatment.
• Advanced interventions like ventricular assistance and cardiac transplantation are options for end-stage disease.